Conferences Trial results 10 December 2023 ASH 2023 – a new EZ battle shapes up Daiichi aims to expand valemetostat into a new use, but Haihe Biopharma isn't far behind. Read more
Trial results 18 September 2023 Bayer looks to clinical validation for $1.5bn Vividion deal Read more